3F9-25956-64490 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-27
Registered in v-safe
2021-03-27
Dose 1 — Pfizer-BioNTech
2021-03-27
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-03-31
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Muscle or body aches

Adult check-in
2021-04-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-02
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-04-03
Health check-in — day 7, dose 1
Feeling: Fair · Fatigue or tiredness, Diarrhea

Adult check-in
2021-04-10
Survey response — day 14, dose 1
MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activities

Free text: More frequent and long-lasting headaches

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-17
Dose 2 — Pfizer-BioNTech
2021-04-19
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-04-21
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Fatigue or tiredness, Diarrhea

Adult check-in
2021-04-22
Survey response — days 1–6 daily, dose 2
MedDRA: Condition aggravated, Cough, Pre-existing disease, Sinus disorder, Withdrawal syndrome — Feeling: Fair · Site: Swelling · Diarrhea

Free text: Have been experiencing a disruption in my SNRI (Effexor), including severe withdrawal symptoms since the day after my second injection. Also experiencing a persistent cough and sinus issues.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-23
Survey response — days 1–6 daily, dose 2
MedDRA: Cough, Pre-existing disease, Sinusitis — Feeling: Poor · Site: Redness, Swelling · Fever · Chills, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Worsening cough and sinusitis

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-24
Survey response — day 7, dose 2
MedDRA: Cough, Sinusitis — Feeling: Poor · Fever · Chills, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities

Free text: Worsening cough and sinusitis

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-01
Survey response — day 14, dose 2
MedDRA: Cough, Productive cough, Wheezing — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Worsening cough for the past 12 days accompanied with phlegm/wheezing

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-01
Report sent to call center — day 14, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-11
Survey response — day 21, dose 2
MedDRA: Cough, Fatigue, Productive cough, Wheezing — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Persisting and productive coughing/wheezing, persisting sinusitis, and fatigue. Has persisted over the past 23 days.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-11
Report sent to call center — day 21, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-17
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-29
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-17
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2022-04-15
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-27	Pfizer-BioNTech
2	2021-04-17	Pfizer-BioNTech

Call center

2 call center cases

2 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 7 — day 14, dose 1

2021-04-10

Symptoms: More frequent and long-lasting headaches

Release 7 — days 1–6 daily, dose 2

2021-04-22

Systemic reaction (other): Have been experiencing a disruption in my SNRI (Effexor), including severe withdrawal symptoms since the day after my second injection. Also experiencing a persistent cough and sinus issues.

2021-04-23

Systemic reaction (other): Worsening cough and sinusitis

Release 7 — day 7, dose 2

2021-04-24

Systemic reaction (other): Worsening cough and sinusitis

Release 8 — day 14, dose 2

2021-05-01

Symptoms: Worsening cough for the past 12 days accompanied with phlegm/wheezing

Release 8 — day 21, dose 2

2021-05-11

Symptoms: Persisting and productive coughing/wheezing, persisting sinusitis, and fatigue. Has persisted over the past 23 days.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Productive cough	✓	✓	✓
SD	Wheezing	✓	✓	✓
SRO	Condition aggravated	✓	✓	✓
SRO	Cough	✓	✓	✓
SRO	Pre-existing disease	✓	✓	✓
SRO	Sinus disorder	✓	✓	✓
SRO	Sinusitis	✓	✓	✓
SRO	Withdrawal syndrome	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release